REPL
Replimune Group Inc
Price:  
9.24 
USD
Volume:  
2,611,012.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

REPL EV/EBITDA

-
Upside

As of 2026-06-10, the EV/EBITDA ratio of Replimune Group Inc (REPL) is -. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. REPL's latest enterprise value is 712.61 mil USD. REPL's TTM EBITDA according to its financial statements is - mil USD. Dividing these 2 quantities gives us the above REPL EV/EBITDA ratio.

Note: valuation result may not be accurate due to the company's negative Enterprise Value.

Range Selected
Trailing P/E multiples - -
Forward P/E multiples - -
Fair Price - -
Upside - -
9.24 USD
Stock Price
- USD
Fair Price

REPL EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA